Health breakthroughs and money matters, in plain words

Home » Rosen Law Probes Blaize Holdings for Securities Fraud

Rosen Law Probes Blaize Holdings for Securities Fraud

By

–

Rosen Law Probes Blaize Holdings for Securities Fraud

NEW YORK, July 11 — A global investor rights law firm is digging into whether Blaize Holdings, Inc. misled its shareholders, after a short seller’s fraud allegations sent the company’s stock tumbling this spring. The investigation, announced July 9 by Rosen Law Firm, centers on claims that Blaize may have issued materially misleading business information to the investing public.

The Rosen Law Firm is preparing a class action lawsuit seeking to recover investor losses. For shareholders who purchased Blaize securities, the firm says they may be entitled to compensation without paying any out-of-pocket fees or costs, operating through a contingency fee arrangement. The firm is actively encouraging investors to join the prospective class action.

The catalyst for the investigation was an April 28, 2026 article by Investing.com titled “Blaize stock tumbles on short seller fraud allegations.” That article reported Blaize shares fell 12% after Pelican Way Research, a short seller, published a report alleging the company’s recent $50 million deal with NeoTensr is fraudulent. The sharp single-day drop erased significant market value for the California-based artificial intelligence company, which trades on the Nasdaq under the ticker BZAI.

Investors left with questions

For the families and individual investors who bought into Blaize, the news raises uncomfortable questions about what they were told — and when. The Rosen Law Firm’s investigation suggests the company may have painted a rosier picture of its business health than the facts warranted. When a short seller’s report lands and a stock drops 12% in a day, the human side of the story becomes about trust: who knew what, and whether shareholders were dealt with fairly.

Blaize has not publicly responded to the short seller’s allegations or to the Rosen investigation. The company, which focuses on AI hardware and software for edge computing, had been positioning itself as a rising player in the competitive chip market. The NeoTensr deal, valued at $50 million, was seen as a significant validation of Blaize’s technology.

What comes next

The Rosen Law Firm is urging investors who purchased Blaize securities to contact Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]. They can also visit the firm’s website to submit information. The firm has a track record of securing settlements for shareholders in securities class actions, including against major technology companies.

For now, the investigation is in its early stages. The court has not yet certified a class, and no lawsuit has been filed. But the clock is ticking for investors who want to be part of any potential recovery. The deadline for lead plaintiff motions will be set once a complaint is filed.

The broader question for the AI sector is whether this case signals increased scrutiny of startup-style deals that promise big revenue but may lack transparency. For the families who bet on Blaize’s future, the answer can’t come soon enough.

Sources

Get breaking stories first on our Telegram channel.

More stories by

Most read

Health & Medicine

Personal Finance

Cancer News

Health News